Screening for Developmental Delay in High-Risk Users of an Urban Pediatric Emergency Department

2010 ◽  
Vol 26 (11) ◽  
pp. 793-797 ◽  
Author(s):  
Devin S. Grossman ◽  
Alan L. Mendelsohn ◽  
Michael G. Tunik ◽  
Benard P. Dreyer ◽  
Samantha B. Berkule ◽  
...  
2012 ◽  
Vol 51 (2) ◽  
pp. 171-178 ◽  
Author(s):  
Lauren Chernick ◽  
Elyse Olshen Kharbanda ◽  
John Santelli ◽  
Peter Dayan

2003 ◽  
Vol 38 (5) ◽  
pp. 426-435 ◽  
Author(s):  
Stuart Levine ◽  
Kay Holbrook ◽  
Barbara O'connor-Pepe ◽  
Deidre Shinn

This continuing feature will focus on recent advancements in the areas of pediatrics and neonatal pharmacology and on methods for reducing medication error risk in this patient population. Most pharmacological agents are designed with the adult in mind, and there is little literature-based data from which to derive dosing schedules and proper drug administration techniques for the pediatric and neonatal patient. Moreover, pharmacological response in this group is not well understood. We hope that this feature will help you provide pharmaceutical care to this high-risk population. Direct questions or comments to Stuart Levine, PharmD, at [email protected] .


2018 ◽  
Vol 25 (11) ◽  
pp. 1193-1203 ◽  
Author(s):  
Sheri‐Ann O. Kaltiso ◽  
V. Jordan Greenbaum ◽  
Maneesha Agarwal ◽  
Courtney McCracken ◽  
April Zmitrovich ◽  
...  

2010 ◽  
Author(s):  
Zorash Montano ◽  
Neda Safvati ◽  
Angela Li ◽  
Ilene Claudius ◽  
Jeffrey I. Gold

Sign in / Sign up

Export Citation Format

Share Document